206 related articles for article (PubMed ID: 23351612)
1. Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function.
Vinish M; Elnabawi A; Milstein JA; Burke JS; Kallevang JK; Turek KC; Lansink CS; Merchenthaler I; Bailey AM; Kolb B; Cheer JF; Frost DO
Int J Neuropsychopharmacol; 2013 Aug; 16(7):1599-609. PubMed ID: 23351612
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function.
Milstein JA; Elnabawi A; Vinish M; Swanson T; Enos JK; Bailey AM; Kolb B; Frost DO
PLoS One; 2013; 8(2):e57308. PubMed ID: 23437365
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.
Xu S; Gullapalli RP; Frost DO
Schizophr Res; 2015 Feb; 161(2-3):452-7. PubMed ID: 25487700
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
El Hage C; Bédard AM; Samaha AN
Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
[TBL] [Abstract][Full Text] [Related]
5. Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brains.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():75-80. PubMed ID: 25149912
[TBL] [Abstract][Full Text] [Related]
6. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
7. Dorsal raphe serotonin neurons inhibit operant responding for reward via inputs to the ventral tegmental area but not the nucleus accumbens: evidence from studies combining optogenetic stimulation and serotonin reuptake inhibition.
Browne CJ; Abela AR; Chu D; Li Z; Ji X; Lambe EK; Fletcher PJ
Neuropsychopharmacology; 2019 Mar; 44(4):793-804. PubMed ID: 30420603
[TBL] [Abstract][Full Text] [Related]
8. Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists.
Liao RM
Pharmacol Biochem Behav; 2008 May; 89(3):367-73. PubMed ID: 18275994
[TBL] [Abstract][Full Text] [Related]
9. Injection of 5-HT into the nucleus accumbens reduces the effects of d-amphetamine on responding for conditioned reward.
Fletcher PJ
Psychopharmacology (Berl); 1996 Jul; 126(1):62-9. PubMed ID: 8853218
[TBL] [Abstract][Full Text] [Related]
10. 6-Hydroxydopamine lesions of nucleus accumbens core abolish amphetamine-induced conditioned activity.
Sellings LH; Clarke PB
Synapse; 2006 May; 59(6):374-7. PubMed ID: 16463400
[TBL] [Abstract][Full Text] [Related]
11. Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit.
Lintas A; Chi N; Lauzon NM; Bishop SF; Gholizadeh S; Sun N; Tan H; Laviolette SR
J Neurosci; 2011 Aug; 31(31):11172-83. PubMed ID: 21813678
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of the caudal and rostral nucleus accumbens to the rewarding effects of a H1-histaminergic receptor blocker as measured with place-preference and self-stimulation behavior.
Zimmermann P; Privou C; Huston JP
Neuroscience; 1999; 94(1):93-103. PubMed ID: 10613500
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens.
Visser AK; Kleijn J; van Faassen MH; Dremencov E; Flik G; Kema IP; Den Boer JA; van Waarde A; Dierckx RA; Bosker FJ
Neurochem Int; 2015 Feb; 81():10-5. PubMed ID: 25542858
[TBL] [Abstract][Full Text] [Related]
14. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.
Salamone JD; Correa M
Behav Brain Res; 2002 Dec; 137(1-2):3-25. PubMed ID: 12445713
[TBL] [Abstract][Full Text] [Related]
15. Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats.
Brake WG; Zhang TY; Diorio J; Meaney MJ; Gratton A
Eur J Neurosci; 2004 Apr; 19(7):1863-74. PubMed ID: 15078560
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens.
Cador M; Taylor JR; Robbins TW
Psychopharmacology (Berl); 1991; 104(3):377-85. PubMed ID: 1924645
[TBL] [Abstract][Full Text] [Related]
17. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
Tan SE
Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
[TBL] [Abstract][Full Text] [Related]
18. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
[TBL] [Abstract][Full Text] [Related]
19. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats.
Lian J; Pan B; Deng C
Pharmacol Rep; 2016 Oct; 68(5):1028-35. PubMed ID: 27428765
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
Tarazi FI; Zhang K; Baldessarini RJ
Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
